Close menu




September 18th, 2020 | 09:22 CEST

Lufthansa, Silver Viper, TUI - does diversification and patience pay off?

  • Investments
Photo credits: pixabay.com

After 6 months of Covid-19 restrictions the world we knew no longer exists. We have had to accept many sacrifices, but did we also feel a loss every time? No more vacation trips abroad and business had to be concluded online without personal contact. Suddenly things started to work out in a way that we never thought possible. Our new world, with adapted everyday rituals, is in the making and with it new investment opportunities are arising.

time to read: 2 minutes | Author: Mario Hose
ISIN: DE0008232125 , CA8283341029 , DE000TUAG000

Table of contents:


    Innocence in the chaos

    Due to the spread of the Corona Pandemic and no fault of their own the share prices of Lufthansa and TUI fell in the first quarter of 2020. Thriving companies with employees around the globe had to stop more or less their entire operations at short notice by government order. In the summer months that followed, there was still hope that a breath of the old habits could return in the autumn months or at the turn of the year at the latest. But at least for now, this does not seem possible.

    State rescues those affected

    Since the latest travel restrictions brought in by the Federal Government for Amsterdam, Vienna and the whole of Spain, everyone is conscious that policy makers will not permit the endangerment of lives. With the fear of an uncontrollable rise in the pandemic the authorities have extended their restrictions once again resulting in the airplanes of Lufthansa remaining unoccupied as well as the high vacancy rate at TUI hotels.

    In the interest of the common good, the state is stepping in with aid packages and rescue packages for the affected industries. In a spirit of solidarity tax money is allocated for emergency situations like these to help bridge the financial requirements of those affected.

    Precious metals as a safe haven

    Investors who want to position themselves in this market environment in order to make short-term profits are certainly better off in industries other than tourism. In addition to the e-commerce and biotech sectors, companies in the precious metals sector in particular have been able to benefit from the increase in money supply by various central banks around the globe. Wealthy people have already been fleeing from fiat currencies to gold and silver for months. The price of gold reached an interim all-time high of over USD 2,075.00 per troy ounce. The price of a troy ounce of silver has risen since mid-year from USD 18.00 per troy ounce to almost USD 30.00.

    Exploration potential in Mexico

    Besides the producers in the mining industry, exploration companies can especially benefit from the increased interest in commodities. For example, Silver Viper Minerals' share price has risen from below CAD 0.32 at its peak to CAD 0.85 since April 2020. The company is on the lookout for gold and silver in Mexico.

    Management has been successful in previous drilling programs in the areas and recently raised a total of CAD 5.1 million from investors at a share price of CAD 0.36. The new capital will allow Silver Viper to continue to develop the La Virginia Project. The market value of the company at its current share price of CAD 0.69 CAD is approximately CAD 43.5 million.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Mario Hose

    Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

    About the author



    Related comments:

    Commented by Juliane Zielonka on September 30th, 2022 | 10:59 CEST

    Biogen, XPhyto, BioNTech: Alzheimer's disease, depression, cancer - Pharma for life

    • Biotechnology
    • Pharma
    • Investments
    • Technology

    About 350 million people worldwide are affected by depression, a disorder of the brain. Each person also has a 16 to 20% chance of becoming depressed. Reason enough for the Canadian Company XPhyto Therapeutics to research a drug that is not addictive and can defeat the mental health-related medical condition. This week, Biogen, among others, achieved a breakthrough with an active substance against Alzheimer's disease. And if you follow the Bundesliga closely, you may be aware of the cases of testicular cancer among the players. Now BioNTech senses a new opportunity...

    Read

    Commented by Fabian Lorenz on September 29th, 2022 | 13:17 CEST

    Up to 200% share price potential: Kion, BioNTech, Aspermont in analyst check

    • Technology
    • Biotechnology
    • Investments

    The profit warning was a shock for Kion shareholders. Accordingly, the share price halved to EUR 20 in September alone. Now analysts are also slashing their estimates. The price targets for the forklift manufacturer are falling accordingly. Berenberg surprises with a high price target for the BioNTech share. At the same time, the analysts emphasize their hope for a continued generous dividend. Shareholders could thus be kept in good spirits until the next blockbuster. The roadshow of Aspermont in Germany has probably also created a good mood. At least the share price has jumped. The current consolidation could be an entry opportunity. Analysts see a price potential of over 200%.

    Read

    Commented by Carsten Mainitz on September 29th, 2022 | 12:01 CEST

    Verbio, Kleos Space, KWS Saat - This news is moving share prices!

    • Space
    • Technology
    • Investments

    Increased uncertainties in geopolitics, rampant inflation with exploding commodity and energy prices, and higher interest rates are making it increasingly difficult for companies to meet the forecasts they issued at the beginning of the year. Recent examples include battery manufacturer Varta and real estate financier Hypoport, which had to withdraw their annual targets. In addition, however, a number of companies have been able to surprise on the upside despite all the challenges.

    Read